Objectives. To determine clinical parameters that could predict occult vascular lesions (OVL) in patients with symptomatic atherosclerosis. Patients and methods. Prospective evaluation of 269 consecutive patients with symptomatic atherosclerosis (cerebral 32%, peripheral vascular 15%, and coronary 53%): complete laboratory, ultrasound exams (carotids, aorta, heart), anklebrachial index. OVL were defined as: abdominal aortic aneurysm, carotid artery stenosis O50%, or left ventricular segmental contraction abnormalities when affecting a different vascular bed from the symptomatic. Clinical predictors of OVL were evaluated by logistic regression analysis. Results. OVL were found in 35 patients (13%): 12 abdominal aortic aneurysms, 21 carotid artery stenosis and 15 segmental left ventricular contraction abnormalities. OVL were associated with peripheral vascular disease (intermittent claudication or reduced ankle-brachial index), cigarette smoking, increased pulse pressure, microalbuminuria and hyperhomocysteinemia. By multivariate analysis, intermittent claudication (odds ratio 5.8; 95% CI 2.6-12.8) and microalbuminuria (OR 4.2; 95% CI 1.7-10.5) were strong independent predictors of OVL. Similar results were obtained when peripheral vascular disease was defined as reduced ankle-brachial index (OR 5.3; 95% CI 2.4-11.7). Conclusions. Clinical and subclinical peripheral vascular disease, as well as microalbuminuria are strong independent predictors of OVL in atherosclerotic patients. A screening study of OVL may be warranted in these patients.
Introduction
Although atherosclerosis is a systemic disease, a thorough assessment of all vascular beds is not generally performed beyond the symptomatic territory. Patients with symptomatic atherosclerosis are more likely to have significant vascular lesions in clinically silent territories than the general population, given the systemic nature of the disease. 1 However, it is unclear whether an exhaustive evaluation of clinically silent territories would translate into a meaningful clinical benefit. In the search for such occult vascular lesions, four important issues must be considered: cost, invasiveness, and accuracy of the screening test; prevalence of the disease; efficacy of interventions to treat the disease; cost of interventions. 2 In this regard the screening of carotid artery stenosis and abdominal aortic aneurysms in patients with lower limb arterial occlusive disease has been demonstrated to be cost-effective. 3, 4 Surprisingly, few studies have addressed a thorough evaluation of all vascular beds beyond the symptomatic territory.
In this study, we performed a non-invasive evaluation of all vascular beds in patients with symptomatic atherosclerosis of any territory in order to determine clinical predictors of important vascular lesions (carotid artery stenosis, abdominal aortic aneurysm, cardiac segmental contractility abnormalities) in asymptomatic territories.
Patients and Methods
The clinical setting for this study was a University Hospital responsible for the medical care of a 250,000 population community. The inclusion criteria were symptomatic atherosclerosis of any territory; coronary (myocardial infarction or unstable angina), cerebral (ischemic non-cardioembolic stroke or transient ischemic attack) or peripheral vascular (claudication grade IIB) attended between July 2000 and June 2002. Exclusion criteria were age O70 years, serum creatinine O3 mg/dl or substitutive renal treatment, life expectancy less than 3 years, inability to understand protocol-derived instructions, rejection of informed consent. All patients were evaluated by the same physician 1 month after the atherothrombotic ischemic event (index event) under a protocol that included: informed consent, detailed medical history of personal and family risk factors, anthropometrics (weight, height, body-mass index, waist circumference), blood pressure determinations (average of two 'casual' measurements in the outpatients clinic; pulse pressure was defined as the difference between systolic and diastolic blood pressure), echocardiogram (Hewlett Packard Sonos 5500), carotid duplex scan (ATL 3500), sonographic measurement of abdominal aortic diameter, ankle-brachial index, fasting laboratory determinations (fractionated cholesterol, triglycerides, Apo B, Apo A1, Lp(a), creatinine, glucose, glycated hemoglobin, high-sensitivity C-reactive protein, homocyst(e)in and microalbuminuria (albumin/creatinine ratio). Important vascular lesions were defined as the presence of internal carotid stenosis O50% (Washington University criteria), 5 abdominal aortic aneurysm (O3 cm diameter), left ventricular segmental contraction abnormalities. These vascular lesions were considered as 'occult' (OVL) when they were not clinically suspected and were present in a different vascular territory from the one that qualified for the inclusion in the study. Besides its prognostic importance, the presence of subclinical peripheral vascular disease was not included as OVL since, it did not imply significant changes in the therapeutic or follow-up attitude.
Statistical analysis
Data were maintained in a computerized database, and were analyzed with SPSS statistical software (SPSS for Windows 11.5). Statistical comparisons were performed with the two-tailed Student's t test for comparison of continuous variables, and either chi 2 or the Fisher's exact test for comparison of discrete variables. Continuous variables with non-normal distribution were logarithmically transformed for the comparisons and are reported as median (interquartile range). Variables associated (p!0.1) with the presence of OVL were entered into a multivariate forward stepwise logistic regression model. p!0.05 was considered statistically significant.
Results
Among 521 potential candidates evaluated, 421 met the inclusion criteria. Hereafter, all data will be referred to the 269 patients (64%) who consented to participate in the study. The index atherothrombotic event was coronary in 52% (30% unstable angina, 22% myocardial infarction), cerebrovascular in 32% (11% transient ischemic attack, 7% lacunar infarct, 14% nonlacunar non-cardioembolic stroke), and lower ischemic arterial disease (grade IIb) in 15%. Mean age was 60G8 years, 80% of the patients were male, 77% were or had been smokers, 76% had hypercholesterolemia, 63% hypertension, 29% diabetes mellitus and 20% a family history of coronary disease.
In the non-invasive study, 12 patients had an abdominal aortic aneurysm, 21 patients had a greater than 50% internal carotid artery stenosis (16 stenosis O50%, four stenosis O80%, one asymptomatic internal carotid artery occlusion), and 15 patients had segmental contractility abnormalities. 35 patients (13%) had one or more OVL in different territories from the one that qualified them for inclusion in the study. The prevalence of OVL were greater in patients included for lower limb arterial ischemic disease (22%) than those included for coronary artery disease (15%) or cerebrovascular disease (6%; pZ0.027) (Fig. 1) .
The relationships between data from the past medical history and the presence of OVL are shown in Table 1 . Patients with a personal history of intermittent claudication were significantly more likely to have OVL (63 vs. 21%, p!0.001). In addition, cigarette smoking (and marginally cumulative years of tobacco use) was also associated with the presence of OVL. Other risk factors were equally distributed among patients with and without OVL.
The relationship between OVL and other clinical and laboratory variables is shown in Table 2 . Of note, lipid values were similar for both groups. In contrast, patients with OVL had increased pulse pressure (pZ 0.005), marginally higher systolic blood pressure (pZ 0.059) but similar diastolic blood pressure. Microalbuminuria was significantly more frequent among patients with OVL (p!0.001). However, glucose or glycated hemoglobin did not differ between both groups. Interestingly, OVL was also associated with increased homocysteine (pZ0.005) and high C-reactive protein (pZ0.09), although the latter did not reach statistical significance.
When all variables associated (p!0.1) with OVL were evaluated in a logistic regression model, the presence of peripheral vascular disease and microalbuminuria were the only independent predictors of OVL (Table 3) . The model was essentially identical whether peripheral vascular disease was defined clinically (intermittent claudication) or by a reduced ankle-brachial index. The predictive power of both microalbuminuria and peripheral vascular disease remained virtually unchanged after adjusting for age and gender.
Discussion
Although atherosclerosis is a systemic disease, it is unclear to what extent a thorough evaluation of silent clinical territories should be performed. Patients with symptomatic atherosclerosis of one territory are likely to have some degree of 'subclinical disease' in asymptomatic territories. Therefore, the main reason for the study of silent vascular beds should be directed to the detection of potentially dangerous lesions and the eventual prevention of clinically severe events. For this purpose we have defined occult vascular lesions in a restrictive manner: (1) corresponding to unsuspected lesions in clinically silent territories, and (2) severe enough to deserve a specific treatment or at least specific follow-up. Most patients (87%) in our series did not fulfill these strict criteria, further suggesting the need of concentrating the efforts on patients of the highest risk. In our series, we have included consecutive patients with clinical atherosclerosis of any territory, providing a representative sample of the full spectrum of atherosclerosis. A remarkable finding in our study is the different prevalence of OVL depending on the initial symptomatic territory. In this regard, the prevalence of OVL was particularly high in patients with lower limb ischemic disease. We have found a prevalence of 22% of OVL in patients with lower limb ischemic disease. Wolf et al. 4 identified abdominal aortic aneurysms in 15% a population of 531 male smokers older than 65 years with lower limb ischemic disease. Other studies have reported that 15-25% of patients with lower limb ischemic disease have significant carotid artery stenosis. 3, 6 Recent data from the SMART study show similar results to ours: the presence of peripheral vascular disease is associated with OVL like carotid stenosis or abdominal aortic aneurysms. 7 Although studies differ in the lesions included in the screening protocol, it is clear that patients with lower limb ischemia have a considerably higher rate of occult vascular lesions. These findings are of particular interest considering the recent results of the asymptomatic carotid surgery trial showing that immediate carotid endarterectomy halved the net 5-year stroke risk from 12 to 6% in patients with an asymptomatic 70% or greater carotid artery stenosis. 8 Not surprisingly, cigarette smoking was associated with OVL. The fact that tobacco use was not selected in the final logistic regression model should not undermine the hazards of smoking. It is likely that the risk conferred by tobacco use is already represented in the model through its tight association with peripheral vascular disease (data not shown). An apparent surprising finding is the lack of association between 
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lipid parameters and OVL. However, it must be emphasized that all patients had already established vascular damage and a sizable proportion of patients (likely those with higher initial values) were receiving treatment with cholesterol lowering agents. Our data demonstrate an association of higher pulse pressure and OVL. Increased pulse pressure has been identified as a predictor of long-term cardiovascular risk, and has even been suggested for inclusion in the Framingham risk score. [9] [10] [11] [12] A high pulse pressure likely reflects increased stiffness of the arterial bed. However, its relationship with occult severe vascular lesions has not specifically been addressed. Several authors have reported that a low diastolic blood pressure (another indicator of the stiffness of the arteries) was related to both OVL and advanced atherosclerosis 3, 13 which is consistent with our data. In spite of its interest, when evaluated by multivariate logistic regression, pulse pressure was no longer an independent predictor of OVL.
Microalbuminuria has been found to be a powerful predictor of cardiovascular events both in diabetic and non-diabetic patients. 14, 15 It is not surprising that in our series microalbuminuria was a powerful predictor of OVL. Several authors have described a similar association between early markers of vascular damage and microalbuminuria, particularly in diabetes. [16] [17] [18] [19] [20] [21] [22] In this regard, it is interesting to note that in our series, neither diabetes by itself nor its short term control (glycated hemoglobin) were predictors of OVL in spite of the fact that microalbuminuria was particularly prominent among diabetics (data not shown). It seems thus, that the long-term consequences of diabetes, such as microalbuminuria rather than diabetes itself are most useful in predicting OVL.
An interesting finding of our study is the increased Data are meanGSD or number of cases (%) unless specified otherwise. * Not normal variables were compared after logarithmic transformation and are expressed as median (interquartile range). NS, nonsignificant (pO0.1). level of homocysteine in patients with OVL. However, homocysteine was not an independent predictor of OVL in multivariate analysis. A number of studies have reported an independent association of hyperhomocysteinemia and cardiovascular disease. 23 In contrast, most clinical studies have failed to show any clinical benefit of homocysteine lowering therapies. 24, 25 Indeed, some authors have suggested that hyperhomocysteinemia may be a marker of vascular damage, rather than a causal risk factor, which is in agreement with our results.
Finally, our study highlights the relevance of peripheral vascular disease as a marker of severe generalized atherosclerosis. First, when the initial clinical presentation of atherosclerosis is peripheral vascular disease (as opposed to coronary or cerebrovascular) the risk of occult severe vascular lesions is higher. Second, peripheral vascular disease remains as a powerful predictor when there are clinical manifestations of other vascular beds. Therefore, peripheral vascular disease must not be ignored or dismissed in the presence of lesions of more 'noble' territories. And third, peripheral vascular disease is an independent powerful predictor in multivariate analysis. Both clinically evident and subclinical disease had a similar predictive power. In our series, asymptomatic peripheral vascular disease was present in less than 10% of cases. However, other studies have reported a higher frequency of clinically unapparent vascular disease, further suggesting the need of 'objective' evaluation such as the one provided by the ankle-brachial index. Its inclusion in the clinical evaluation of coronary or cerebrovascular disease may help identify patients with a particularly high risk.
Our study has several important limitations. First of all, although prospectively designed, its cross-sectional nature is helpful in identifying clinical markers rather than risk factors. Data regarding blood pressure and lipid values should be interpreted with caution, since a significant proportion of patients were receiving treatment with lipid and blood pressure lowering drugs. However, this is the way we usually see patients in the clinical setting, and, therefore, our data may be of practical value. We have found that two simple markers are particularly helpful in identifying patients with unsuspected severe vascular lesions. Most often microalbuminuria has been used as a marker of increased cardiovascular risk before the clinical manifestations of atherosclerosis. Here, we report that microalbuminuria is still useful as a marker of more advanced lesions after the appearance of clinical vascular disease. Furthermore, the presence of peripheral vascular disease (both clinical and subclinical) is a powerful independent marker of occult vascular lesions in different territories.
It is clear that not every patient with clinical atherosclerosis have the same probability of having an occult cardiovascular lesion. In this series, as well as in the SMART study, a small proportion of the patients had an OVL. Thus, extensive screening of the vascular tree may not be warranted in all atherosclerotic patients. Our results suggest that two simple clinical factors: presence of intermittent claudication and microalbuminuria can help identify a subgroup of patients with a particularly high risk of having OVL.
